![Bradley Meyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bradley Meyer
Directeur/Bestuurslid bij
AVENG LIMITED
Vermogen: 629 006 $ op 31-08-2026
Profiel
Bradley Carl Meyer is currently an Independent Non-Executive Director at Aveng Ltd. since 2021, an Independent Non-Executive Director at Santhera Pharmaceuticals Holding AG since 2023, and a Director at Quotient Ltd. since 2023.
Additionally, Mr. Meyer serves as a Director at Biocartis SA and Quotient Suisse SA. Former roles include Managing Director at Perella Weinberg Partners from 2014 to 2015, Member of the Financial Restructuring Group at Houlihan Lokey, Inc. from 2003 to 2012, and Member positions at Millstein & Co. LP and Ducera Partners LLC.
Education includes undergraduate studies at Harvard University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 34.062 ( 0,22% ) | 629 006 $ | 31-08-2026 |
Actieve functies van Bradley Meyer
| Bedrijven | Functie | Begin |
|---|---|---|
| AVENG LIMITED | Directeur/Bestuurslid | 28-05-2021 |
| QUOTIENT LIMITED | Directeur/Bestuurslid | 16-02-2023 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Directeur/Bestuurslid | 27-06-2023 |
Quotient Suisse SA
 Quotient Suisse SA BiotechnologyHealth Technology Develops transfusion diagnostics products to hospitals and blood banks | Directeur/Bestuurslid | - |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Directeur/Bestuurslid | - |
Eerdere bekende functies van Bradley Meyer
| Bedrijven | Functie | Einde |
|---|---|---|
| PERELLA WEINBERG PARTNERS | Corporate Officer/Principal | 01-02-2015 |
| HOULIHAN LOKEY, INC. | Corporate Officer/Principal | 01-01-2012 |
Millstein & Co. LP
 Millstein & Co. LP Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
Ducera Partners LLC
 Ducera Partners LLC Regional BanksFinance Provides investment banking services | Corporate Officer/Principal | - |
Opleiding van Bradley Meyer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
69
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aveng Ltd.
 Aveng Ltd. Engineering & ConstructionIndustrial Services Engages in infrastructure development | Industrial Services |
Houlihan Lokey, Inc.
 Houlihan Lokey, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
Quotient Ltd.
 Quotient Ltd. Medical SpecialtiesHealth Technology Develops and manufactures conventional reagent products | Health Technology |
Millstein & Co. LP
Millstein & Co. LP Investment ManagersFinance Acts as an alternative investment manager | Finance |
Quotient Suisse SA
Quotient Suisse SA BiotechnologyHealth Technology Develops transfusion diagnostics products to hospitals and blood banks | Health Technology |
Ducera Partners LLC
Ducera Partners LLC Regional BanksFinance Provides investment banking services | Finance |
Perella Weinberg Partners
 Perella Weinberg Partners Investment ManagersFinance Provides financial and strategic advisory services | Finance |
